Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Circ Cardiovasc Imaging. 2010 May 4;3(4):392–397. doi: 10.1161/CIRCIMAGING.109.912071

Table 1.

Baseline Characteristics of the participants*

All LV Hypertrophy p value
(n=353) No (n=291) Yes (n=62)
Demographics
Age (yrs) 64±12 64±12 63±12 0.80
Men 191(54) 157(54) 34(55) 0.90
BMI (g/m2) 31±7 31±7 31±8 0.91
Historical Data (%)
Smoking 150(42) 123(42) 27(44) 0.89
Hypertension 243(69) 197(68) 46(74) 0.56
Diabetes mellitus 126(36) 93(32) 33(53) 0.006
Hypercholesterolemia 194(55) 158(54) 36(58) 0.79
CHF 55(16) 41(14) 14(23) 0.23
Prior MI 126(36) 98(34) 28(45) 0.09
Medication (%)
ACE inhibitor/ARB 107(30) 77(26) 30(48) 0.003
Statin 106(30) 90(31) 16(26) 0.62
β-blocker 123(35) 97(33) 26(42) 0.33
Hemodynamic
Rest HR 73±14 73±14 73±14 0.86
Rest SBP 142±23 141±22 144±26 0.42
Rest DBP 79±13 79±12 78±18 0.83
Peak HR 130±16 131±15 125±18 0.03
Peak SBP 148±27 148±26 149±28 0.87
Peak DBP 77±16 77±16 79±16 0.37
Cardiac MRI
LVEF (%) 55±13 57±12 48±14 <0.001
LV mass(g) 139±47 124±32 207±47 <0.001
LV mass index(g/m2) 69±22 62±13 105±19 <0.001
Inducible ischemia 110(31) 80(27) 30(48) 0.001
Event (%)
Hard event 71(20) 51(17) 20(32) 0.009
Cardiac death 43(12) 27(9) 15(24) <0.001
MI 38(11) 30(10) 7(11) 0.79

For continuous variables, data are presented as mean ± standard deviation. For dichotomous variables, the number and percentage of participants with the condition are shown.

*

LV hypertrophy defined as LV mass index >96 g/m2 and 77 g/m2 in men and women, respectively.

p value for comparison of patients with or without LVH

Abbreviations: ACE = Angiotensin-converting enzyme; ARB= Angiotensin receptor blocker; BMI= Body mass index; CHF= Congestive heart failure; DBP = diastolic blood pressure; LVEF= Left ventricular ejection fraction; HR= heart rate; MI= Myocardial infarction; SBP= systolic blood pressure